Trials / Completed
CompletedNCT01688622
Glypican4 and CTRP5 in Metabolic Syndrome and the Effect of Exercise on These Adipokines
Effects of Exercise on Glypican4,CTRP3,5 and RBP4 Levels and Circulating Levels of These Adipokines in the Subjects With or Without Metabolic Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Korea University · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Glypican4, CTRP3, CTRP5 are emerging novel adipokines mediating obesity and inflammation related disorders. RBP4 and adiponectin are well known important adipokines. Therefore, we examine the circulating levels of theses adipokines in the subjects with or without metabolic syndrome. Furthermore, we tried to clarify the effect of exercise on the circulating these adipokines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | 3months Exercise | training session consisting of a brief warm-up, followed by an approximately 45-min session of aerobic exercise at an intensity of 60-75% of the age-predicted maximum heart rate (approximately 300 kcal/day) and a 20-min muscle strength train- ing programme (approximately 100 kcal/day), followed by a brief cool-down period. |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2012-09-20
- Last updated
- 2012-09-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01688622. Inclusion in this directory is not an endorsement.